LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Acrivon Therapeutics, Inc.

Similar companies to Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc. Tech Stack

Acrivon Therapeutics, Inc. uses 8 technology products and services including Cloudflare CDN, Cloudflare, Shopify, and more. Explore Acrivon Therapeutics, Inc.'s tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Shopify
    E-commerce
  • Google Font API
    Font Scripts
  • React
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • PHP
    Programming Languages
  • Adobe Tag Manager
    Tag Management

Media & News

Acrivon Therapeutics, Inc.'s Email Address Formats

Acrivon Therapeutics, Inc. uses at least 1 format(s):
Acrivon Therapeutics, Inc. Email FormatsExamplePercentage
FLast@acrivon.comJDoe@acrivon.com
92%
FMiddleLast@acrivon.comJMichaelDoe@acrivon.com
6%
First@acrivon.comJohn@acrivon.com
1%
FL@acrivon.comJD@acrivon.com
1%

Frequently Asked Questions

Where is Acrivon Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc.'s main headquarters is located at 700 North Main Street Cambridge, Massachusetts 02139 US. The company has employees across 2 continents, including North AmericaEurope.

What is Acrivon Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc. is a publicly traded company; the company's stock symbol is ACRV.

What is Acrivon Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc.'s official website is acrivon.com and has social profiles on LinkedIn.

How much revenue does Acrivon Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2024, Acrivon Therapeutics, Inc.'s annual revenue reached $3.8M.

What is Acrivon Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Acrivon Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2024, Acrivon Therapeutics, Inc. has approximately 77 employees across 2 continents, including North AmericaEurope. Key team members include Chief Legal Officer: M. M.Chief Medical Officer: J. C.Chief Financial Officer: R. H.. Explore Acrivon Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Acrivon Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Acrivon Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc.'s tech stack includes Cloudflare CDNCloudflareShopifyGoogle Font APIReactOpen GraphPHPAdobe Tag Manager.

What is Acrivon Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc.'s email format typically follows the pattern of . Find more Acrivon Therapeutics, Inc. email formats with LeadIQ.

How much funding has Acrivon Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2024, Acrivon Therapeutics, Inc. has raised $130M in funding. The last funding round occurred on Apr 09, 2024 for $130M.

When was Acrivon Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Acrivon Therapeutics, Inc. was founded in 2018.
Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Our method is widely applicable across drug classes and modalities. We specifically apply our approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single gene driver mutations or synthetic lethal contexts. Leveraging our unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in our wholly-owned subsidiary in Lund, Sweden.

Section iconCompany Overview

Headquarters
700 North Main Street Cambridge, Massachusetts 02139 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ACRV
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $130M

    Acrivon Therapeutics, Inc. has raised a total of $130M of funding over 3 rounds. Their latest funding round was raised on Apr 09, 2024 in the amount of $130M.

  • $10M

    Acrivon Therapeutics, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $130M

    Acrivon Therapeutics, Inc. has raised a total of $130M of funding over 3 rounds. Their latest funding round was raised on Apr 09, 2024 in the amount of $130M.

  • $10M

    Acrivon Therapeutics, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.